These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34508901)

  • 1. Prefrontal Cortex Activation and Stopping Performance Underlie the Beneficial Effects of Atomoxetine on Response Inhibition in Healthy Volunteers and Those With Cocaine Use Disorder.
    Zhukovsky P; Morein-Zamir S; Ziauddeen H; Fernandez-Egea E; Meng C; Regenthal R; Sahakian BJ; Bullmore ET; Robbins TW; Dalley JW; Ersche KD
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Nov; 7(11):1116-1126. PubMed ID: 34508901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomoxetine restores the response inhibition network in Parkinson's disease.
    Rae CL; Nombela C; Rodríguez PV; Ye Z; Hughes LE; Jones PS; Ham T; Rittman T; Coyle-Gilchrist I; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
    Brain; 2016 Aug; 139(Pt 8):2235-48. PubMed ID: 27343257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving response inhibition in Parkinson's disease with atomoxetine.
    Ye Z; Altena E; Nombela C; Housden CR; Maxwell H; Rittman T; Huddleston C; Rae CL; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
    Biol Psychiatry; 2015 Apr; 77(8):740-8. PubMed ID: 24655598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nicotine and atomoxetine on brain function during response inhibition.
    Kasparbauer AM; Petrovsky N; Schmidt PM; Trautner P; Weber B; Sträter B; Ettinger U
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):235-246. PubMed ID: 30552041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects.
    DeVito EE; Herman AI; Konkus NS; Zhang H; Sofuoglu M
    Pharmacol Biochem Behav; 2017 Aug; 159():55-61. PubMed ID: 28716656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.
    Passamonti L; Luijten M; Ziauddeen H; Coyle-Gilchrist ITS; Rittman T; Brain SAE; Regenthal R; Franken IHA; Sahakian BJ; Bullmore ET; Robbins TW; Ersche KD
    Psychopharmacology (Berl); 2017 Aug; 234(15):2289-2297. PubMed ID: 28551713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.
    Chamberlain SR; Hampshire A; Müller U; Rubia K; Del Campo N; Craig K; Regenthal R; Suckling J; Roiser JP; Grant JE; Bullmore ET; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2009 Apr; 65(7):550-5. PubMed ID: 19026407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease.
    O'Callaghan C; Hezemans FH; Ye R; Rua C; Jones PS; Murley AG; Holland N; Regenthal R; Tsvetanov KA; Wolpe N; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
    Brain; 2021 Sep; 144(8):2513-2526. PubMed ID: 33783470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural correlates of atomoxetine improving inhibitory control and visual processing in Drug-naïve adults with attention-deficit/hyperactivity disorder.
    Fan LY; Chou TL; Gau SS
    Hum Brain Mapp; 2017 Oct; 38(10):4850-4864. PubMed ID: 28657141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.
    Baskin BM; Nic Dhonnchadha BÁ; Dwoskin LP; Kantak KM
    Psychopharmacology (Berl); 2017 Oct; 234(19):2897-2909. PubMed ID: 28730282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder.
    Chamberlain SR; Del Campo N; Dowson J; Müller U; Clark L; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2007 Nov; 62(9):977-84. PubMed ID: 17644072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease.
    Borchert RJ; Rittman T; Passamonti L; Ye Z; Sami S; Jones SP; Nombela C; Vázquez Rodríguez P; Vatansever D; Rae CL; Hughes LE; Robbins TW; Rowe JB
    Neuropsychopharmacology; 2016 Jul; 41(8):2171-7. PubMed ID: 26837463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
    Ye Z; Rae CL; Nombela C; Ham T; Rittman T; Jones PS; Rodríguez PV; Coyle-Gilchrist I; Regenthal R; Altena E; Housden CR; Maxwell H; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
    Hum Brain Mapp; 2016 Mar; 37(3):1026-37. PubMed ID: 26757216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
    Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer MJ; Simmons A; Rubia K
    Cereb Cortex; 2014 Jan; 24(1):174-85. PubMed ID: 23048018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Modulatory Effects of Atomoxetine on Aberrant Connectivity During Attentional Processing in Cocaine Use Disorder.
    Nestor LJ; Luijten M; Ziauddeen H; Regenthal R; Sahakian BJ; Robbins TW; Ersche KD
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Mar; 9(3):314-325. PubMed ID: 37619670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Lin HY; Gau SS
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv094. PubMed ID: 26377368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy.
    Ota T; Iida J; Nakanishi Y; Sawada S; Matsuura H; Yamamuro K; Ueda S; Uratani M; Kishimoto N; Negoro H; Kishimoto T
    Psychiatry Clin Neurosci; 2015 Mar; 69(3):161-70. PubMed ID: 25359429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenaline transporter blockade increases fronto-parietal functional connectivity relevant for working memory.
    Hernaus D; Casales Santa MM; Offermann JS; Van Amelsvoort T
    Eur Neuropsychopharmacol; 2017 Apr; 27(4):399-410. PubMed ID: 28291572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
    Kowalczyk OS; Cubillo AI; Smith A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
    Bradshaw SE; Agster KL; Waterhouse BD; McGaughy JA
    Brain Res; 2016 Jun; 1641(Pt B):245-57. PubMed ID: 26774596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.